{"id":2745,"date":"2026-05-08T01:30:00","date_gmt":"2026-05-07T23:30:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=c13e4f1d1144ce63339af3a3459a3fe1"},"modified":"2026-05-08T01:30:00","modified_gmt":"2026-05-07T23:30:00","slug":"travere-therapeutics-to-participate-at-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=2745","title":{"rendered":"Travere Therapeutics to Participate at Upcoming Investor Conferences"},"content":{"rendered":"

SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that company management will participate in the following upcoming investor conferences:<\/p><\/a><\/a>

\nBofA Securities 2026 Health Care Conference\n<\/b>Presenting on Wednesday, May 13, 2026, at 5:20 p.m. ET (2:20 p.m. PT)<\/p>

\n2026 Jefferies Global Healthcare Conference\n<\/b>Presenting on Wednesday, June 3, 2026, at 8:45 a.m. ET<\/p>

\nGoldman Sachs 47th Annual Global Healthcare Conference 2026\n<\/b>Presenting on Monday, June 8, 2026, at 11:20 a.m. ET<\/p>

\nLive webcasts of the presentations will be accessible on the Investor page of Travere\u2019s website at ir.travere.com\/events-and-presentations<\/a>. Replays will be available for up to 30 days following each event.<\/p>

\nAbout Travere Therapeutics<\/b><\/p>

\nAt Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent \u2013 that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope \u2013 today and tomorrow. For more information, visit travere.com<\/a>.<\/p> Contacts<\/b>

\nInvestors:\n888-969-7879\nir@travere.com<\/a><\/p>

\nMedia:\n888-969-7879\nmediarelations@travere.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

SAN DIEGO–(BUSINESS WIRE)–Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that company management will participate in the following upcoming investor conferences:
\nBofA Securities 2026 Health Care Conference
\nPresenting on Wednesday, May 13, …<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2745","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/2745","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2745"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/2745\/revisions"}],"predecessor-version":[{"id":2746,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/2745\/revisions\/2746"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2745"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2745"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2745"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}